Cargando…
A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected
The paradigm of targeted therapy was pioneered for chronic myeloid leukemia (CML). The advent of tyrosine kinase inhibitors (TKIs) has led to marked improvements in responses and overall survival; however, there is still a subset of patients that are either resistant through a multitude of mechanism...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359993/ https://www.ncbi.nlm.nih.gov/pubmed/32700137 http://dx.doi.org/10.1007/s40487-018-0058-6 |